BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6814877)

  • 1. Possible effect of drugs on arterial wall metabolism in experimental atherosclerosis.
    Mrhová O; Urbanová D
    Czech Med; 1982; 5(3):165-75. PubMed ID: 6814877
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pyridinolcarbamate on enzyme changes in the arterial wall of rats intoxicated with allylamine.
    Mrhová O; Shimamoto T; Numano F
    Biochem Pharmacol; 1975 Mar; 24(5):567-70. PubMed ID: 1125060
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperreactive arterial endothelial cells in atherogenesis. Effect of smooth muscle relaxants.
    Shimamoto T; Moriya K; Kobayashi DV; Takahashi T; Numano F
    Adv Exp Med Biol; 1977; 82():234-6. PubMed ID: 920366
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of pyridinolcarbamate on serum and vascular wall lipids in the rabbit].
    Sanmald R; Wagener H; Schlierf G; Dornbusch T; Sann E
    Verh Dtsch Ges Inn Med; 1972; 78():1230-2. PubMed ID: 4665504
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of phthalazinol (EG 626) and pyridinolcarbamate (Anginin) on lipolytic enzyme activities in rat adipose tissue -in vivo and in vitro-.
    Tomita T; Yonekura I; Shirasaki Y; Hayashi E; Numano F
    Jpn J Pharmacol; 1980 Feb; 30(1):65-73. PubMed ID: 6249948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pyridinolcarbamate on lipid metabolism of normal and arteriosclerotic intima in human femoral arteries].
    Horsch AK; Gilli J; Schreiter U
    Verh Dtsch Ges Inn Med; 1974; 80():952-4. PubMed ID: 4454699
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of Mercurascan on some enzymes of striated muscle in acute and chronic stages of ischaemia.
    Mrhová O; Kolc J; Málek P
    Biochem Pharmacol; 1978 Feb; 27(3):359-60. PubMed ID: 619917
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Effect of pyridinolcarbamate on the lipid metabolism of normal and atherosclerotic intima in human femoral arteries].
    Horsch AK; Gilli J; Schreiter U
    MMW Munch Med Wochenschr; 1974 May; 116(22):1112. PubMed ID: 4211589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyridinolcarbamate in diabetic angiopathies].
    Indovina I; Furitano G; Notarbartolo A; Citarrella P; Scaffidi A
    Minerva Med; 1978 May; 69(24):1681-97. PubMed ID: 566399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in some enzyme activities of the arterial wall in post-hypophyseal hormone experimental arteriopathies].
    Magrassi F; De Martini R; Gastaldi G; Bertieri AL
    Pathologica; 1967; 59(879):503-11. PubMed ID: 4319299
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effect of pyridinolcarbamate on the vascular wall of rats with hypervitaminosis D.
    Mrhová O; Shimamoto T; Numano F
    Atherosclerosis; 1972; 16(1):1-8. PubMed ID: 4262650
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 13. Vessel wall metabolism in SHR rats in relation to atherosclerosis.
    Mrhová O; Albrecht I; Urbanová D
    Ann N Y Acad Sci; 1976; 275():302-10. PubMed ID: 1070276
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthetic studies of antiatherogenic agents. (VI) Syntheses of carbamate derivative of substituted phthalazinones (author's transl)].
    Eguchi Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1977; 11():49-53. PubMed ID: 284539
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies of parmidin (pyridinolcarbamate) effect on microvascular permeability of the lungs, skin and mesentery].
    Gorizontoba MP; Shvarts GIa
    Biull Eksp Biol Med; 1979 Sep; 88(9):272-5. PubMed ID: 519015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pyridinolcarbamate (PDC) on surface microvessels in man: preliminary findings.
    Rouen LR; Terry EN; Clauss RH; Redisch W
    Bibl Anat; 1975; 13():358-9. PubMed ID: 1231780
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid synthesis in normal and atherosclerotic human intima in vitro under the effect of pyridinolcarbamate].
    Gilli J; Horsch AK; Leyendecker I; Schreiter U
    Vasa; 1976; 5(2):88-94. PubMed ID: 973428
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to the study of the biochemical behavior of the arterial wall in aging and atherogenesis. Similarities and differences in these 2 states].
    Fontaine R; Ebel A; Pantesco V; Kempf E; Mack G
    Angiology; 1968 Mar; 19(3):172-97. PubMed ID: 4230715
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic changes in the arterial wall and endothelial injury in experimental methioninaemia.
    Mrhová O; Hladovec J; Urbanová D
    Cor Vasa; 1988; 30(1):73-9. PubMed ID: 3378448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of capillary permeability by a combination of pyridinolcarbamate and adenosine].
    Igual A; Vericat Cadesas F; Beaus R
    Arch Farmacol Toxicol; 1978 Apr; 4(1):88-9. PubMed ID: 697407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.